AstraZeneca and Eli Lilly have joined the ranks of drugmakers around the world trying to repurpose existing drugs for use in severely-ill COVID-19 patients as the number of cases worldwide approaches 2 million. A trial of Lilly’s JAK inhibitor…
First study of Gilead’s remdesivir in COVID-19 reveals little
Two-thirds of coronavirus patients treated with Gilead’s antiviral drug remdesivir seemed to get a clinical benefit from the drug in a just-published study – but it’s still far too early to say if it is effective. That is the preliminary…
WHO: More than 70 COVID-19 Vaccines are in Development, Three in Clinical Trials
More than 2 million people have been diagnosed with COVID-19, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization (WHO), there are now more…
GSK and Sanofi Join Forces to Develop a COVID-19 Vaccine
As the world continues to wait with bated breath for a vaccine against COVID-19, GlaxoSmithKline and Sanofi have joined forces to develop an adjuvanted vaccine for COVID-19. The two companies are eying the second half of this year to begin…
Med comms agency 90TEN acquired by Envision Pharma Group
90TEN has been acquired by Envision Pharma Group in a move its new parent company says will deepen and diversify its offering. The London-based healthcare communications agency (whose team are pictured above) will retain its brand, while bringing its behavioral…
EMA clears compassionate use of Gilead’s remdesivir for COVID-19
The EU drugs regulator says Gilead Sciences’ antiviral drug remdesivir should be made available for people seriously ill with COVID-19, despite limited data on its efficacy. The EMA’s human medicines committee (CHMP) says the antiviral drug can be used on…
NOVOTECH SELECTED FOR NEW COVID-19 CLINICAL TRIAL IN ASIA-PACIFIC
Novotech has been engaged by Revive Therapeutics Ltd, a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, to pursue human clinical trials for Bucillamine in the treatment of infectious diseases, including…
FDA relaxes infusion pumps and thermometers guidelines
The Food and Drug Administration (FDA) has released relaxed guidelines for infusion pumps and clinical thermometers due to the COVID-19 pandemic. The relaxed guidance hopes to increase the availability of these devices which are currently in high demand, and adds…
Iceland’s Sidekick produces national COVID-19 patient tracker
The Iceland-based digital health company Sidekick has adapted its technology to provide remote monitoring, triage and support for COVID-19 patients with the help of the Reykjavik-based computer games firm CCP. Sidekick is providing the country’s emergency management authorities with a…
GSK to collaborate with Chinese biotech on COVID-19 vaccine
GlaxoSmithKline has announced plans to collaborate with China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 coronavirus. The companies are testing a recombinant protein-based coronavirus vaccine candidate, known as COVID-19 XWG-03, which is being developed by Innovax with…
